Inhibikase Therapeutics annual net debt
2021
2022
2023
2024
2025
Inhibikase Therapeutics Net Debt Growth & History (IKT)
Inhibikase Therapeutics's net debt was −$178.8M for fiscal 2025.
View full Inhibikase Therapeutics company overviewInhibikase Therapeutics annual net debt history
| Fiscal year | Period ended | Net debt | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | −$178.8M | −$81.5M | — |
| 2024 | 2024-12-31 | −$97.3M | −$88.8M | — |
| 2023 | 2023-12-31 | −$8.5M | −$2.0M | — |
| 2022 | 2022-12-31 | −$6.5M | $34.0M | — |
| 2021 | 2021-12-31 | −$40.5M | — | — |
Inhibikase Therapeutics quarterly net debt
Q1.21
Q2.21
Q3.21
Q4.21
Q3.22
Q4.22
Q1.23
Q2.23
Q3.23
Q4.23
Q1.24
Q2.24
Q3.24
Q4.24
Q1.25
Q2.25
Q3.25
Q4.25
Q1.26
Q2.26
| Fiscal quarter | Period ended | Net debt | Change | YoY change |
|---|---|---|---|---|
| Q2 2026 | 2026-06-30 | −$31.2M | $46.5M | — |
| Q1 2026 | 2026-03-31 | −$49.6M | $23.7M | — |
| Q4 2025 | 2025-12-31 | −$178.8M | −$81.5M | — |
| Q3 2025 | 2025-09-30 | −$38.3M | −$37.6M | — |
| Q2 2025 | 2025-06-30 | −$77.7M | −$74.9M | — |
| Q1 2025 | 2025-03-31 | −$73.3M | −$71.4M | — |
| Q4 2024 | 2024-12-31 | −$97.3M | −$88.8M | — |
| Q3 2024 | 2024-09-30 | −$623,000 | $13.7M | — |
| Q2 2024 | 2024-06-30 | −$2.8M | −$1.4M | — |
| Q1 2024 | 2024-03-31 | −$1.9M | $1.4M | — |
| Q4 2023 | 2023-12-31 | −$8.5M | −$2.0M | — |
| Q3 2023 | 2023-09-30 | −$14.3M | −$9.3M | — |
| Q2 2023 | 2023-06-30 | −$1.3M | — | — |
| Q1 2023 | 2023-03-31 | −$3.3M | — | — |
| Q4 2022 | 2022-12-31 | −$6.5M | $34.0M | — |
| Q3 2022 | 2022-09-30 | −$5.0M | $39.6M | — |
| Q4 2021 | 2021-12-31 | −$40.5M | — | — |
| Q3 2021 | 2021-09-30 | −$44.6M | — | — |
| Q2 2021 | 2021-06-30 | −$46.6M | — | — |
| Q1 2021 | 2021-03-31 | −$8.4M | — | — |
Inhibikase Therapeutics net debt trends
Between the periods ended 2021-12-31 and 2025-12-31, Inhibikase Therapeutics's net debt decreased from −$40.5M to −$178.8M, a change of −$138.3M. The latest reported quarter, Q2 2026, shows −$31.2M.
About the metric
What net debt means
Net debt compares a company’s interest-bearing debt with its cash and cash equivalents. Positive net debt means debt exceeds cash, while a negative value indicates the company has more cash than debt on this measure.
Calculation and source
How net debt is calculated
TickerStat calculates net debt as total interest-bearing debt minus cash and cash equivalents at the same reporting-period end. Short-term investments are not subtracted because they are not included in the standardized cash series. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Inhibikase Therapeutics source filings ↗